CELLECTAR BIOSCIENCES INC
CLRB · NASDAQ
Updated at 2026-10-13 15:18:11
- Today's High
- $1.60
- Today’s Low
- $1.44
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.45
- Previous Close
- $1.43
- Volume
- 186.13K
- Market Cap
- $13.51M
- P/E Ratio
- --
- EPS
- $-4.59
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, UNITED STATES, 07932
- Country
- US
- Listing Date
- 2005-05-20
- Fiscal Year End
- December
- Shares Outstanding
- 7.99M
- CIK
- 0001279704
- Website
- www.cellectar.com
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of cancer. The company is headquartered in Florham Park, New Jersey.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$7.19M
2026-03-31
$5.9M
2025-12-31
$5.69M
2025-09-30
$4.85M
Net Income
2026-06-30
-$6.93M
2026-03-31
-$5.65M
2025-12-31
-$5.29M
2025-09-30
-$4.44M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.57
2026-03-31
$-1.33
2025-12-31
$-0.53
2025-09-30
$-1.41
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$6.89M
2026-03-31
-$5.76M
2025-12-31
-$5.24M
2025-09-30
-$4.39M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $7.19M | $5.9M | $5.69M | $4.85M |
| Net Income | -$6.93M | -$5.65M | -$5.29M | -$4.44M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.57 | $-1.33 | $-0.53 | $-1.41 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$6.89M | -$5.76M | -$5.24M | -$4.39M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.